Measurement of urinary Dickkopf-3 uncovered silent progressive kidney injury in patients with chronic obstructive pulmonary disease.

[1]  Fabian J Theis,et al.  Publisher Correction: Inhibition of LTβR signalling activates WNT-induced regeneration in lung , 2020, Nature.

[2]  D. Fliser,et al.  WNT–β-catenin signalling — a versatile player in kidney injury and repair , 2020, Nature Reviews Nephrology.

[3]  A. Ortiz,et al.  Targeting the progression of chronic kidney disease , 2020, Nature Reviews Nephrology.

[4]  J. Kellum,et al.  Association between urinary dickkopf-3, acute kidney injury, and subsequent loss of kidney function in patients undergoing cardiac surgery: an observational cohort study , 2019, The Lancet.

[5]  H. Watz,et al.  Consequences of chronic kidney disease in chronic obstructive pulmonary disease , 2019, Respiratory Research.

[6]  H. Kauczor,et al.  Combined effects of lung function, blood gases and kidney function on the exacerbation risk in stable COPD: Results from the COSYCONET cohort. , 2019, Respiratory medicine.

[7]  M. Jørgensen,et al.  Progressive Decline in Estimated Glomerular Filtration Rate in Patients With Diabetes After Moderate Loss in Kidney Function—Even Without Albuminuria , 2019, Diabetes Care.

[8]  L. Navar,et al.  Canagliflozin Prevents Intrarenal Angiotensinogen Augmentation and Mitigates Kidney Injury and Hypertension in Mouse Model of Type 2 Diabetes Mellitus , 2019, American Journal of Nephrology.

[9]  C. Kent.  The Effect of Social Media in Social Interaction , 2019 .

[10]  Douglas E Schaubel,et al.  US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States. , 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  M. Rudnicki,et al.  Dickkopf-3 (DKK3) in Urine Identifies Patients with Short-Term Risk of eGFR Loss. , 2018, Journal of the American Society of Nephrology : JASN.

[12]  J. Williams,et al.  Prevention of the progression of renal injury in diabetic rodent models with preexisting renal disease with chronic endothelin A receptor blockade. , 2018, American journal of physiology. Renal physiology.

[13]  Junwei Yang,et al.  Wnt/β-Catenin-Promoted Macrophage Alternative Activation Contributes to Kidney Fibrosis. , 2017, Journal of the American Society of Nephrology : JASN.

[14]  D. Bolignano,et al.  Non‐proteinuric rather than proteinuric renal diseases are the leading cause of end‐stage kidney disease: Clinical Epidemiology in Nephrology , 2017, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  Youhua Liu,et al.  Matrix Metalloproteinase-7 Is a Urinary Biomarker and Pathogenic Mediator of Kidney Fibrosis. , 2017, Journal of the American Society of Nephrology : JASN.

[16]  Ashutosh Kumar Singh,et al.  Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, Lancet.

[17]  P. Heagerty,et al.  Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014. , 2016, JAMA.

[18]  R. Holle,et al.  The German COPD cohort COSYCONET: Aims, methods and descriptive analysis of the study population at baseline. , 2016, Respiratory medicine.

[19]  Wenling Kang,et al.  Atrasentan increased the expression of klotho by mediating miR-199b-5p and prevented renal tubular injury in diabetic nephropathy , 2016, Scientific Reports.

[20]  T. Hielscher,et al.  Tubular Dickkopf-3 promotes the development of renal atrophy and fibrosis. , 2016, JCI insight.

[21]  Youhua Liu,et al.  Wnt/β-catenin signalling and podocyte dysfunction in proteinuric kidney disease , 2015, Nature Reviews Nephrology.

[22]  S. Weiss,et al.  Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease , 2015, Nature Medicine.

[23]  E. Porrini,et al.  Non-proteinuric pathways in loss of renal function in patients with type 2 diabetes. , 2015, The lancet. Diabetes & endocrinology.

[24]  Kai-Uwe Eckardt,et al.  Evolving importance of kidney disease: from subspecialty to global health burden , 2013, The Lancet.

[25]  G. Remuzzi,et al.  Glomerular Hyperfiltration and Renal Disease Progression in Type 2 Diabetes , 2012, Diabetes Care.

[26]  Harold I Feldman,et al.  Estimating glomerular filtration rate from serum creatinine and cystatin C. , 2012, The New England journal of medicine.

[27]  Hans Clevers,et al.  Wnt/β-Catenin Signaling and Disease , 2012, Cell.

[28]  N. Tangri,et al.  A predictive model for progression of chronic kidney disease to kidney failure. , 2011, JAMA.

[29]  M. Woodward,et al.  Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis , 2010, The Lancet.

[30]  Elizabeth Selvin,et al.  Poor glycemic control in diabetes and the risk of incident chronic kidney disease even in the absence of albuminuria and retinopathy: Atherosclerosis Risk in Communities (ARIC) Study. , 2008, Archives of internal medicine.

[31]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[32]  Rury R Holman,et al.  Risk Factors for Renal Dysfunction in Type 2 Diabetes , 2006, Diabetes.

[33]  Quan Dong Nguyen,et al.  Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. , 2003, JAMA.

[34]  A. Nemmar,et al.  Effects of the SGLT-2 Inhibitor Canagliflozin on Adenine-Induced Chronic Kidney Disease in Rats. , 2019, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology.